American International Group, Inc. Immunic, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$3.13 - $12.25 $29,087 - $113,839	-9,293 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$9.54 - $14.26 $6,248 - $9,340	-655 Reduced 6.58%	9,293 $105,000
Q4 2021 Feb 11, 2022	SELL	$7.34 - $10.25 $2,179 - $3,044	-297 Reduced 2.9%	9,948 $95,000
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $12,509 - $20,652	1,554 Added 17.88%	10,245 $91,000
Q2 2021 Aug 13, 2021	BUY	$11.76 - $16.85 $64,044 - $91,765	5,446 Added 167.83%	8,691 $107,000

Q1 2021 May 07, 2021	BUY	$14.21 - $25.3 $113 - $202	8 Added 0.25%	3,245 $52,000
Q4 2020 Feb 12, 2021	SELL	$14.8 - $20.37 $1,376 - $1,894	-93 Reduced 2.79%	3,237 $49,000
Q3 2020 Nov 04, 2020	BUY	$11.74 - $22.0 $14,404 - $26,994	1,227 Added 58.35%	3,330 $62,000
Q2 2020 Aug 12, 2020	BUY	$5.67 - $15.86 $11,924 - $33,353	2,103 New	2,103 $25,000

57.6M

600

254K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $35.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.